Perspectives of personalized approach to prevention and treatment of anticonvulsant-induced osteoporosis via action on vitamin D exchange and VDR expression
Open Access
- 14 November 2021
- journal article
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in Personalized Psychiatry and Neurology
- Vol. 1 (2), 46-62
- https://doi.org/10.52667/2712-9179-2021-1-2-46-62
Abstract
Anticonvulsant-induced osteoporosis (AIO) and associated pain syndromes and patient disabilities are an important interdisciplinary medical problem generated by various molecular, genetic and pathophysiological mechanisms. AIO are the most important pathological processes associated with chronic pain in adults with epilepsy. Standard approaches to their prevention and treatment do not always solve the problem of the progression of the pathological process and chronicity of AIO. This is the reason for the search for new personalized strategies for the prevention and treatment of AIO. Vitamin D metabolism, expression and specificity of vitamin D receptors (VDRs) may play a key role in the development of AIO and chronic back pain in patients with epilepsy. The aim of the study was to review publications on changes in the vitamin D system in patients with AIO. We searched for articles published in e-Library, PubMed, Oxford Press, Clinical Case, Springer, Elsevier, and Google Scholar. The search was carried out by key-words and their combinations. The role of vitamin D and VDR in the development of AIO and the chronicity of back pain has been demonstrated mainly in animal models and humans. Associative genetic studies have shown that single nucleotide variants (SNVs) of the VDR gene encoding VDR may be associated with the development of osteoporosis of the spine (including those associated with the intake of an anticonvulsants). The prospects for the use of vitamin D preparations for modulating the effect of anticonvulsants used to treat epilepsy are discussed. Genetic association studies of VDR gene SNVs are important for understanding the genetic predictors of AIO and chronic back pain in patients with epilepsy, as well as for developing new personalized pharmacotherapy strategies.Keywords
This publication has 81 references indexed in Scilit:
- Antiepileptic Treatment Is Associated with Bone Loss: Difference in Drug Type and Region of InterestJournal of Nuclear Medicine Technology, 2013
- A review of the effect of anticonvulsant medications on bone mineral density and fracture riskThe American Journal of Geriatric Pharmacotherapy, 2010
- Vitamin D and Human Skeletal MuscleScandinavian Journal of Medicine & Science in Sports, 2009
- Evidence of association of Vitamin D receptor Apa I gene polymorphism with bone mineral density in postmenopausal women with osteoporosisClinical Rheumatology, 2009
- Evaluation of Bone Turnover in Epileptic Children Using OxcarbazepinePediatric Neurology, 2008
- Vitamin D Status and the Metabolic SyndromeNutrition Reviews, 2006
- Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the EvidenceCalcified Tissue International, 2006
- Central Nervous System–Active Medications and Risk for Falls in Older WomenJournal of the American Geriatrics Society, 2002
- Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean womenJournal of Human Genetics, 2000
- Involvement of Calmodulin in 1α,25-Dihydroxyvitamin D3 Stimulation of Store-operated Ca2+ Influx in Skeletal Muscle CellsOnline Journal of Public Health Informatics, 2000